Medicus Pharma Ltd Stock Market Value
MDCXW Stock | 0.88 0.08 8.33% |
Symbol | Medicus |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medicus Pharma. If investors know Medicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medicus Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medicus Pharma is measured differently than its book value, which is the value of Medicus that is recorded on the company's balance sheet. Investors also form their own opinion of Medicus Pharma's value that differs from its market value or its book value, called intrinsic value, which is Medicus Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medicus Pharma's market value can be influenced by many factors that don't directly affect Medicus Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medicus Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medicus Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medicus Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Medicus Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medicus Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medicus Pharma.
11/24/2024 |
| 12/24/2024 |
If you would invest 0.00 in Medicus Pharma on November 24, 2024 and sell it all today you would earn a total of 0.00 from holding Medicus Pharma Ltd or generate 0.0% return on investment in Medicus Pharma over 30 days. Medicus Pharma is related to or competes with Opus Genetics,, and Telix Pharmaceuticals. Medicus Pharma is entity of United States More
Medicus Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medicus Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medicus Pharma Ltd upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 13.24 | |||
Information Ratio | 0.1745 | |||
Maximum Drawdown | 45.79 | |||
Value At Risk | (18.67) | |||
Potential Upside | 23.33 |
Medicus Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicus Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medicus Pharma's standard deviation. In reality, there are many statistical measures that can use Medicus Pharma historical prices to predict the future Medicus Pharma's volatility.Risk Adjusted Performance | 0.1497 | |||
Jensen Alpha | 2.27 | |||
Total Risk Alpha | 1.87 | |||
Sortino Ratio | 0.1676 | |||
Treynor Ratio | (2.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medicus Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medicus Pharma Backtested Returns
Medicus Pharma is out of control given 3 months investment horizon. Medicus Pharma has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-seven different technical indicators, which can help you to evaluate if expected returns of 2.17% are justified by taking the suggested risk. Use Medicus Pharma Risk Adjusted Performance of 0.1497, mean deviation of 9.62, and Downside Deviation of 13.24 to evaluate company specific risk that cannot be diversified away. Medicus Pharma holds a performance score of 13 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.1, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Medicus Pharma are expected to decrease slowly. On the other hand, during market turmoil, Medicus Pharma is expected to outperform it slightly. Use Medicus Pharma total risk alpha, as well as the relationship between the downside variance and rate of daily change , to analyze future returns on Medicus Pharma.
Auto-correlation | 0.60 |
Good predictability
Medicus Pharma Ltd has good predictability. Overlapping area represents the amount of predictability between Medicus Pharma time series from 24th of November 2024 to 9th of December 2024 and 9th of December 2024 to 24th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medicus Pharma price movement. The serial correlation of 0.6 indicates that roughly 60.0% of current Medicus Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.6 | |
Spearman Rank Test | 0.52 | |
Residual Average | 0.0 | |
Price Variance | 0.01 |
Medicus Pharma lagged returns against current returns
Autocorrelation, which is Medicus Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medicus Pharma's stock expected returns. We can calculate the autocorrelation of Medicus Pharma returns to help us make a trade decision. For example, suppose you find that Medicus Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Medicus Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medicus Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medicus Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medicus Pharma stock over time.
Current vs Lagged Prices |
Timeline |
Medicus Pharma Lagged Returns
When evaluating Medicus Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medicus Pharma stock have on its future price. Medicus Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medicus Pharma autocorrelation shows the relationship between Medicus Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Medicus Pharma Ltd.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.